Unknown

Dataset Information

0

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism.

ABSTRACT: Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This commentary suggests treating nonalcoholic steatohepatitis through a newly identified mechanism consistent with pathophysiology. (Hepatology Communications 2017;1:193-197).

SUBMITTER: Colca JR 

PROVIDER: S-EPMC5721453 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism.

Colca Jerry R JR   McDonald William G WG   McCommis Kyle S KS   Finck Brian N BN  

Hepatology communications 20170418 3

Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This commentary suggests treating nonalcoholic steatohepatitis through a newly identified mechanism consistent with pathophysiology. (<i>Hepatology Communications</i> 2017;1:193-197). ...[more]

Similar Datasets

Unknown Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism.
| S-EPMC6352854 | biostudies-literature
Unknown Identifying and Treating Nonalcoholic Fatty Liver Disease.
| S-EPMC6366580 | biostudies-literature
Unknown NNMT activation can contribute to the development of fatty liver disease by modulating the NAD + metabolism.
| S-EPMC5988709 | biostudies-literature
Genomics p53 regulates ethanol metabolism via ALDH2 modulating the development of alcoholic fatty liver disease
2023-02-08 | GSE222743 | GEO
Unknown Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.
| S-EPMC3988578 | biostudies-literature
Unknown Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.
| S-EPMC7792990 | biostudies-literature
Unknown The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier.
| S-EPMC7407832 | biostudies-literature
Unknown Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota.
| S-EPMC6164583 | biostudies-literature
Transcriptomics Network Pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism
2023-01-29 | GSE223990 | GEO
Unknown Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
| S-EPMC7132133 | biostudies-literature